News
1h
Investor's Business Daily on MSNAstraZeneca ADR Sees RS Rating Rise To 71
AstraZeneca ADR AZN had its Relative Strength (RS) Rating upgraded from 61 to 71 Thursday — a welcome improvement, but still below the 80 or better score you look for. Please watch the video at ...
Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six ...
9h
TipRanks on MSNGSK Expands Share Buyback Programme with New Purchase
GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...
The FDA has accepted GSK’s application for priority review of gepotidacin, a first-in-class antibiotic for uncomplicated ...
KNOWING where to invest your cash is difficult as there are thousands of companies to choose from. That’s why Holly Mead, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results